Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status.
Fehm T, Becker S, Duerr-Stoerzer S, Sotlar K, Mueller V, Wallwiener D, Lane N, Solomayer E, Uhr J
Breast Cancer Res 2007, 9:R74
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S
Breast Cancer Research 2009, 11:R59 (10 August 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
2.


Research article    
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S
Breast Cancer Research 2009, 11:R46 (9 July 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.